LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.68 | 21.74 | 2024 | 3418 | 0.5920 | 0.8614 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.68 | 21.74 | 2734 | 3418 | 0.7997 | 0.9397 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.68 | 21.74 | 2817 | 3418 | 0.8240 | 0.9476 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.65 | 21.74 | 2016 | 3754 | 0.5370 | 0.8395 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.65 | 21.74 | 2160 | 3754 | 0.5754 | 0.8566 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.65 | 21.74 | 2921 | 3754 | 0.7781 | 0.9336 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.65 | 21.74 | 2978 | 3754 | 0.7932 | 0.9386 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.62 | 21.74 | 2210 | 4150 | 0.5324 | 0.8404 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.62 | 21.74 | 2293 | 4150 | 0.5524 | 0.8493 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.62 | 21.74 | 3116 | 4150 | 0.7507 | 0.9257 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 45.62 | 21.74 | 3223 | 4150 | 0.7765 | 0.9343 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.59 | 21.74 | 2314 | 4492 | 0.5151 | 0.8347 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.59 | 21.74 | 2411 | 4492 | 0.5367 | 0.8446 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.59 | 21.74 | 3251 | 4492 | 0.7237 | 0.9177 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.59 | 21.74 | 3420 | 4492 | 0.7613 | 0.9303 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.56 | 21.74 | 2504 | 4838 | 0.5175 | 0.8380 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.56 | 21.74 | 2589 | 4838 | 0.5351 | 0.8459 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.56 | 21.74 | 3516 | 4838 | 0.7266 | 0.9198 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.56 | 21.74 | 3641 | 4838 | 0.7525 | 0.9284 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.53 | 21.74 | 2663 | 5150 | 0.5170 | 0.8395 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.53 | 21.74 | 2753 | 5150 | 0.5345 | 0.8473 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.53 | 21.74 | 3672 | 5150 | 0.7129 | 0.9160 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.53 | 21.74 | 3828 | 5150 | 0.7432 | 0.9262 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.50 | 21.74 | 2840 | 5425 | 0.5234 | 0.8439 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.50 | 21.74 | 2934 | 5425 | 0.5407 | 0.8514 | MN20160310_N01 | D10 |